Back to Blog
Covid 19 vaccines5/26/2023 Now, two companies are planning to change that through the development of COVID-19 vaccines inhaled through the nose.ĬanSino Biologics, a Chinese pharmaceutical company, recently received approval from the National Medical Products Administration of China for Convidecia Air, their recombinant vaccine delivered via inhalation, as a nasal spray.īharat Biotech International, a biotechnology company headquartered in India, has been granted approval under Restricted Use in Emergency Situation in India for its iNCOVACC recombinant vaccine administered intranasally as nasal drops. Up to now, all approved COVID-19 vaccines have been subcutaneous - that is, administered under the skin, often by injection into the upper area of the arm. Visit our coronavirus hub for the most recent information on the COVID-19 pandemic.Īs the COVID-19 pandemic continues, new vaccines to prevent infection with SARS-CoV-2, the virus that causes COVID-19m are under constant development.
0 Comments
Read More
Leave a Reply. |